Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: Expression of a ventricular-like genomic signature

Circulation Research

Volumn 96, Issue 9, 2005, Pages 1022-1029

  Barth, Andreas S ^a   Merk, Sylvia ^b   Arnoldi, Elisabeth ^a   Zwermann, Ludwig ^a   Kloos, Patrick ^a   Gebauer, Mathias ^c,e   Steinmeyer, Klaus ^c,e   Bleich, Markus ^c,d,e   Kääb, Stefan ^a   Hinterseer, Martin ^a   Kartmann, Heike ^a   Kreuzer, Eckart ^a   Dugas, Martin ^b   Steinbeck, Gerhard ^a   Nabauer, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e SANOFI   (France)

Author keywords

Atrial fibrillation; Atrial myocardium; Functional genomics; Gene expression

Indexed keywords

ARTICLE; CELL COMMUNICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HEART ATRIUM FIBRILLATION; HEART MUSCLE; HEART VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINUS RHYTHM; TRANSCRIPTION REGULATION;

ATRIAL FIBRILLATION; CALCIUM; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENOME, HUMAN; HEART ATRIA; HEART VENTRICLES; HUMANS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 21044459633     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000165480.82737.33     Document Type: Article

References (43)

1. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54:230-246.
2. Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, Ishida M, Shingu T, Sueda T, Yoshizumi M, Chayama K. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardial. 2004;43:818-825.
3. Dobrev D, Ravens U. Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol. 2003;98:137-148.
4. Goette A, Lendeckel U, Klein HU. Signal transduction systems and atrial fibrillation. Cardiovasc Res. 2002;54:247-258.
5. Lai LP, Lin JL, Lin CS, Yen HM, Tsay YG, Lee CF, Lee HH, Chang ZF, Hwang JJ, Su MJ, Tseng YZ, Huang SKS. Functional genomic study on atrial fibrillation using cDNA microarray and two-dimensional protein electrophoresis techniques and identification of the myosin regulatory light chain isoform reprogramming in atrial fibrillation. J Cardiovasc Electrophys. 2004;15:214-223.
6. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249-264.
7. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9440-9445.
8. Bussey KJ, Kane D, Sunshine M, Narasimhan S, Nishizuka S, Reinhold WC, Zeeberg B, Ajay, Weinstein JN. MatchMiner: A tool for batch navigation among gene and gene product identifiers. Genome Biol. 2003;4:R27.
9. Sturn A, Quackenbush J, Trajanoski Z. Genesis: Cluster analysis of microarray data. Bioinformatics. 2002;18:207-208.
10. Al Shahrour F, Diaz-Uriarte R, Dopazo J. FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics. 2004;20:578-580.
11. Barth AS, Merk S, Amoldi E, Zwermann L, Kloos P, Gebauer M, Steinmeyer K, Bleich M, Kääb S, Pfeufer A, Überfuhr P, Dugas M, Steinbeck G, Nabauer M. Functional profiling of human atrial and ventricular gene expression. Eur J Physiol. In Press.
12. Fedak PW, Smookler DS, Kassiri Z, Ohno N, Leco KJ, Verma S, Mickle DAG, Watson KL, Hojilla CV, Cruz W, Weisel RD, Li RK, Khokha R. TIMP-3 Deficiency Leads to Dilated Cardiomyopathy. Circulation. 2004;110:2401-2409.
13. Garratt AN, Ozcelik C, Birchmeier C. ErbB2 pathways in heart and neural diseases. Trends Cardiovasc Med. 2003;13:80-86.
14. Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex - Signaling strength and integrity for the sarcolemma. Circ Res. 2004;94:1023-1031.
15. Akhurst RJ. TGFbeta signaling in health and disease. Nat Genet. 2004;36:790-792.
16. Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Clausters M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kajii T, Jondeau G, Ohta T, Kishino T, Furukawa Y, Nakamura Y, Niikawa N, Boileau C, Matsumoto N. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet. 2004;36:855-860.
17. Sébillon P, Bouchier C, Bidot LD, Bonne G, Ahamed K, Charron P, Drouin-Garraud V, Millaire A, Desrumeaux G, Benaiche A, Charniot JC, Schwanz K, Villard E, Komajda M. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Gen. 2003;40:560-567.
18. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation - a study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
19. Thijssen VLJL, Ausma J, Borgers M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc Res. 2001;52:14-24.
20. White CW, Kerber RE, Weiss HR, Marcus ML. The effects of atrial fibrillation on atrial pressure-volume and flow relationships. Circ Res. 1982;51:205-215.
21. Ausma J, Coumans WA, Duimel H, Van der Vusse GJ, Allessie MA, Borgers M. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res. 2000;47:788-796.
22. Naroiska NA, van Loon RB, Boontje NM, Zaremba R, Eiras Penas S, Russell J, Spiegelenberg SR, Huybregts MAJM, Visser FC, de Jong JW, van der Velden J, Stienen GJM. Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue. Cardiovasc Res. 2005;65:221-229.
23. Ohki-Kaneda R, Ohashi J, Yamamoto K, Ueno S, Ota J, Choi YL, Koinuma K, Yamashita Y, Misawa Y, Fuse K, Ikeda U, Shimada K, Mano H. Cardiac function-related gene expression profiles in human atrial myocytes. Biochem Biophys Res Comm. 2004;320:1328-1336.
24. Schotten U, Ausma J, Stellbrink C, Sabatschus I; Vogel M; Frechen D; Schoendube F, Hanrath P, Allessie MA. Cellular Mechanisms of Depressed Atrial Contractility in Patients With Chronic Atrial Fibrillation. Circulation. 2001;103:691-698.
25. Kubisch C, Wollnik B, Maass A, Meyer R, Vetter H, Neyses L. Immediate-early gene induction by repetitive mechanical but not electrical activity in adult rat cardiomyocytes. FEBS Lett. 1993;335:37-40.
26. McDonough PM, Glembotski CC. Induction of atrial natriuretic factor and myosin light chain-2 gene expression in cultured ventricular myocytes by electrical stimulation of contraction. J Biol Chem. 1992;267:11665-11668.
27. Akar JG, Everett TH, Ho RY, Craft J, Haines DE, Somlyo AP, Somlyo AV. Intracellular chloride accumulation and subcellular elemental distribution during atrial fibrillation. Circulation. 2003;107:1810-1815.
28. Ausma J, Dispersyn GD, Duimel H, Thone F, Donck LV, Allessie MA, Borgers M. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol. 2000;32:355-364.
29. 2+-handling by atrial tachycardia: evidence for a role in loss of rate-adaptation. Cardiovasc Res. 2002;54:416-426.
30. Lee SH, Yu WC, Cheng JJ, Hung CR, Ding YA, Chang MS, Chen SA. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling. Circulation. 2000;101:200-206.
31. Piper HM, Isenberg G, eds. Isolated Cardiac Myocytes. Boca Raton, Fla: CRC Press, Inc; 1989.
32. Kumar C, Saidapet C, Delaney P, Mendola C, Siddiqui MAQ. Expression of ventricular-type myosin light chain messenger RNA in spontaneously hypertensive rat atria. Circ Res. 1988;62:1093-1097.
33. Wankerl M, Bohm M, Morano I, Ruegg JC, Eichhorn M, Erdmann E. Calcium sensitivity and myosin light chain pattern of atrial and ventricular skinned cardiac fibers from patients with various kinds of cardiac disease. J Mol Cell Cardiol. 1990;22:1425-1438.
34. Ausma J, Thone F, Dispersyn GD, Flameng W, Vanoverschelde JL, Raemaekers FCS, Borgers M. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol Cell Biochem. 1998;186:159-168.
35. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004;95:135-145.
36. Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L, Ramaekers F, Allessie M, Borgers M. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol. 2001;33:2083-2094.
37. Knaapen MWM, Vrolijk BCM, Wenink ACG. Ultrastructural changes of the myocardium in the embryonic rat heart. Anatom Rec. 1997;248:233-241.
38. Storey KB. Mammalian hibernation: transcriptional and translational controls. Adv Exp Med Biol. 2003;543:21-38.
39. Tuinenburg AE, Brundel BJJM, Van Gelder IC, Henning RH, Van den Berg MP, Driessen C, Grandjean JG, van Gilst WH, Crijns HJGM. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophys. 1999;10:827-835.
40. 10 expression. Circulation. 2002;106:90.
41. Kumagai K, Fukuchi M, Ohta J, Baba S, Oda K, Akimoto H, Kagaya Y, Watanabe J, Tabayashi K, Shirato K. Expression of the von Willebrand factor in atrial endocardium is increased in atrial fibrillation depending on the extent of structural remodeling. Circulation J. 2004;68:321-327.
42. Brundel BJJM, Van Gelder IC, Tuinenburg AE, Wietses M, Van Veldhuisen DJ, van Gilst WH, Crijns HJGM, Henning RH. Endothelin system in human persistent and paroxysmal atrial fibrillation. J Cardiovasc Electrophys. 2001;12:737-742.
43. Kirmanoglou K, Hannekum A, Schafler AE. Expression of mortalin in patients with chronic atrial fibrillation. Basic Res Cardiol. 2004;99:404-408.